NLRP3 Inflammasome Activation by 17β-Estradiol Is a Potential Therapeutic Target in Hepatocellular Carcinoma Treatment

Scientists evaluated the role of NLRP3 inflammasome and pyroptosis in HCC and to clarify the potential mechanism by which 17β-estradiol could be used as a protective factor against HCC.